TREVIAMET XR 50/1000MG TAB

TREVIAMET XR 50/1000MG combines sitagliptin and metformin HCl in an extended-release formulation designed to help manage type 2 diabetes. This dual-action medication works by increasing insulin secretion and improving insulin sensitivity, helping to regulate blood sugar levels effectively. The extended-release tablet provides convenient once-daily dosing for better medication adherence. Suitable for patients requiring combination therapy to achieve optimal glycemic control. Always use as directed by your healthcare provider.